Company: RGNT
Filing Date: 2025-07-07
Form Type: F-1/A
Source: 0001213900-25-061821
Chunk: 180

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-07-07
Form: F-1/A
Chunk 180
---
 Executive Officers

For so long as we qualify
as a foreign private issuer, we are not required to comply with the proxy rules applicable to U.S. domestic companies, including the
requirement applicable to emerging growth companies to disclose the compensation of our chief executive officer and other two most highly
compensated executive officers on an individual, rather than an aggregate, basis. Nevertheless, regulations promulgated under the Companies
Law will require us, after we become a public company, to disclose the annual compensation of our five most highly compensated office
holders on an individual basis, rather than on an aggregate basis. This disclosure will not be as extensive as that required of a U.S.
domestic issuer. We intend to commence providing such disclosure, at the latest, in the proxy statement for our first annual general
meeting of shareholders following this offering, which will be furnished under cover of a Form 6-K and we may elect to provide such information
at an earlier date.

Compensation of Directors and Executive Officers

Directors. Under the
Companies Law, the compensation of our directors requires the approval of our compensation committee, the subsequent approval of the
board of directors and, unless exempted under regulations promulgated under the Companies Law, the approval of the shareholders at a
general meeting. If the compensation of our directors is inconsistent with our stated compensation policy, then, those provisions that
must be included in the compensation policy according to the Companies Law must have been considered by the compensation committee and
board of directors, and shareholder approval will also be required, provided that:

| ● | at least a majority of                                                                                                           
 the shares held by shareholders who are not controlling shareholders and do not have a personal interest in such matter, present 
 and voting at such meeting, are voted in favor of the compensation package, excluding abstentions; or                            |

| ● | the total number of shares                                                                                                          
 of non-controlling shareholders and shareholders who do not have a personal interest in such matter voting against the compensation 
 package does not exceed 2% of the aggregate voting rights in the company.                                                           |

Executive officers other than the chief executive officer. The Companies Law requires the approval of the compensation of a public company’s executive
officers (other than the chief executive officer) in the following order: (i) the compensation committee, (ii) the company’s board
of directors, and (iii) if such compensation arrangement is inconsistent with the company’s stated compensation policy, the company’s
shareholders (by a special